Sun Biomedical Technologies Profile last edited on: 1/10/2007
CAGE: 1YMR2
UEI:
Business Identifier: NO Business Identifier is currently available for this company. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 23
County: Kern
Congr. District: 23
County: Kern
Public Profile
Sun Biomedical Technologies researchs on early genetic responses to infectious diseases and environmental hazards, as well as development of peptide antibiotics for use as a Bacillus spore decontaminating agents, as detectors for Bacillus spores, and for potential treatment of anthrax spore inhalation and infection
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2005 | 2 | Army | $799,843 | |
| Project Title: High-Throughput Proteomics Strategy for Detection and Identification of Biomarkers of Malaria Exposure | ||||
| 2004 | 1 | NSF | $75,000 | |
| Project Title: Sublancin 168 for Bacillus Spores Detection, Inactivation and Decontamination | ||||
| 2003 | 2 | CBD | $798,792 | |
| Project Title: Molecular Signatures of Biological Pathogens | ||||
Key People / Management
Earl W Ferguson -- President
Guck Ooi
Guck Ooi
Company News
There are no news available.
